Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciSparc Ltd. ( (SPRC) ) just unveiled an update.
In August 2025, SciSparc Ltd. issued 999,528 ordinary shares to investors who converted their debentures into equity, following agreements made in February 2025. This conversion leaves $175,000 of the debentures outstanding, impacting the company’s share structure and potentially its market positioning.
More about SciSparc Ltd.
SciSparc Ltd. operates in the biotechnology industry, focusing on the development of therapies for central nervous system disorders. The company is known for its innovative approach to treating conditions such as Alzheimer’s disease and Tourette syndrome.
Average Trading Volume: 305,480
Technical Sentiment Signal: Sell
Current Market Cap: $1.62M
For detailed information about SPRC stock, go to TipRanks’ Stock Analysis page.